Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Lüthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M.

Nat Med. 2006 Apr;12(4):401-9. Epub 2006 Apr 2.

PMID:
16582916
2.
3.
4.

Advances in the treatment of Chronic Granulomatous Disease by gene therapy.

Ott MG, Seger R, Stein S, Siler U, Hoelzer D, Grez M.

Curr Gene Ther. 2007 Jun;7(3):155-61. Review.

PMID:
17584034
5.

Inserting optimism into gene therapy.

Naldini L.

Nat Med. 2006 Apr;12(4):386-8. No abstract available.

PMID:
16598281
6.
7.

Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.

Brenner S, Whiting-Theobald NL, Linton GF, Holmes KL, Anderson-Cohen M, Kelly PF, Vanin EF, Pilon AM, Bodine DM, Horwitz ME, Malech HL.

Blood. 2003 Oct 15;102(8):2789-97. Epub 2003 Jun 26.

9.

Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.

Zentilin L, Tafuro S, Serra C, Falaschi A, Giacca M.

Ann Ist Super Sanita. 1998;34(4):447-55.

PMID:
10234875
10.

Gene therapy of chronic granulomatous disease.

Grez M, Becker S, Saulnier S, Knöss H, Ott MG, Maurer A, Dinauer MC, Hoelzer D, Seger R, Hossle JP.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S99-104.

PMID:
10933200
11.

Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.

Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Malech HL, Gottesman MM, Tsuruo T.

J Gene Med. 2003 May;5(5):366-76.

PMID:
12731085
13.

Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.

Zentilin L, Tafuro S, Grassi G, Garcia R, Ventura A, Baralle F, Falaschi A, Giacca M.

Exp Cell Res. 1996 Jun 15;225(2):257-67.

PMID:
8660913
14.

Gene therapy for chronic granulomatous disease.

Kang EM, Malech HL.

Methods Enzymol. 2012;507:125-54. doi: 10.1016/B978-0-12-386509-0.00007-7.

PMID:
22365772
15.

Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

Calmels B, Ferguson C, Laukkanen MO, Adler R, Faulhaber M, Kim HJ, Sellers S, Hematti P, Schmidt M, von Kalle C, Akagi K, Donahue RE, Dunbar CE.

Blood. 2005 Oct 1;106(7):2530-3. Epub 2005 Jun 2.

17.
18.

Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.

Kang HJ, Bartholomae CC, Paruzynski A, Arens A, Kim S, Yu SS, Hong Y, Joo CW, Yoon NK, Rhim JW, Kim JG, Von Kalle C, Schmidt M, Kim S, Ahn HS.

Mol Ther. 2011 Nov;19(11):2092-101. doi: 10.1038/mt.2011.166. Epub 2011 Aug 30.

19.

Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.

Becker S, Wasser S, Hauses M, Hossle JP, Ott MG, Dinauer MC, Ganser A, Hoelzer D, Seger R, Grez M.

Hum Gene Ther. 1998 Jul 20;9(11):1561-70.

PMID:
9694155
20.

X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.

Porter CD, Parkar MH, Levinsky RJ, Collins MK, Kinnon C.

Blood. 1993 Oct 1;82(7):2196-202.

Supplemental Content

Support Center